Obninsk Chem-Pharmaceutical Company

Obninsk Chem-Pharmaceutical Company (OCPC) is a prominent Russian pharmaceutical manufacturer and the foundational entity of the Mirpharm Group. Established in 1999 in the science city of Obninsk, the company specializes in the full-cycle production of active pharmaceutical ingredients (APIs) and finished dosage forms. OCPC focuses on high-tech import substitution and the development of treatments for rare (orphan) diseases, with a diverse portfolio covering oncology, neurology, and gynecology. The company operates GMP-certified facilities and maintains robust R&D capabilities, often collaborating with leading Russian medical research centers to bring innovative and essential medicines to the domestic and EAEU markets.